医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

DCAT Launches Networking Event in Barcelona to Serve Expanding Global Membership

2016年08月16日 PM08:30
このエントリーをはてなブックマークに追加


 

ROBBINSVILLE, N.J.

With over 40 percent of its new member companies headquartered outside North America, the Drug, Chemical & Associated Technologies Association (DCAT) is introducing a special networking event at Casa Llotja de Mar in Barcelona, Spain on Wednesday, October 5, 2016 from 6:00 to 8:30 pm. The networking reception, DCAT After The Show, is scheduled immediately following CPhI Worldwide so that members will have plenty of time to connect with colleagues and establish new business contacts before attending late-night customer events.

“With the growth of the organization’s membership globally, the DCAT leadership expanded the networking opportunities for members who may not attend DCAT Week, our flagship event held annually in New York City,” said DCAT President Dr. Folker Ruchatz, Corporate Vice President, Consumer Health Care Operations and Third Party Management at Boehringer Ingelheim GmbH. “DCAT is a business development association for the global pharmaceutical manufacturing industry and we are committed to helping our members expand their network of industry contacts.”

Registration for DCAT After The Show is $79.00 USD and includes food, beverage and transportation to Casa Llotja de Mar, a magnificent 14th century historic landmark on Barcelona’s waterfront. To learn more about this exciting opportunity visit www.dcat.org/AfterTheShow .

About DCAT

DCAT is a 501(c)6 not-for-profit, member-supported, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. www.dcat.org

View source version on businesswire.com: http://www.businesswire.com/news/home/20160816005152/en/

CONTACT

Drug, Chemical & Associated Technologies Association
Erin
Sanders, 609-208-1888
Director of Communications
esanders@dcat.org
or
Brandwidth
Solutions LLC
Debra Harrsch, 215-997-8575
dharrsch@brandwidthsolutions.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Apros Therapeutics Announces IND Clearance from U.S. FDA to Initiate the Trial of APR003, an Orally-Administered Gastrointestinal/Liver-Targeted TLR7 Agonist for Treatment of Advanced Colorectal Cancer (CRC) with Malignant Liver Lesions
  • Taiwan Innotech Expo (TIE) Showcases Strong Ecosystems in the Post-Pandemic World
  • Dr. Reddy’s Laboratories announces the launch of Over-The-Counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren® Arthritis Pain in the U.S. Market
  • GC Pharma Taps Small Molecule AI Expert Atomwise to Expand Hemophilia Franchise
  • 随着越来越多的客户和合作伙伴使用Denodo冠状病毒数据门户计划来对抗和最小化COVID-19的影响,其采纳率在不断提高